Riskpilot← Back to searchSign inGet full accessLinné IVF AB
ABActiveOrg 5569885584UppsalaGeneral medical practice activities · NACE 8621Est. 20140 employees
Revenue 2024
SEK 0
EBITDA margin
—
-400% vs 2023
Equity ratio
98.9%
Financial strength
Net profit 2024
SEK 16,6M
+13% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -55K | -400% |
| Net profit | SEK 16,6M | +13% |
| Total assets | SEK 71,9M | +31% |
| Equity | SEK 71,1M | +31% |
| Employees | 0 | — |
Legal name
Linné IVF AB
Org number
5569885584
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 november 2014
Share capital
SEK 56 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva medicinska utredningar och behandlingar, konsultverksamhet inom detta område samt därmed förenlig verksamhet.
Address
Uppsala
Phone
+4618551302
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −17 | −65 | −65 | −11 | −55 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −17 | −65 | −65 | −11 | −55 |
| Net financials | 13 669 | 17 944 | 17 944 | 18 568 | 21 021 |
| Profit before tax | 13 652 | 17 879 | 17 879 | 18 558 | 20 966 |
| Tax | −2 926 | −3 706 | −3 706 | −3 859 | −4 330 |
| Net profit | 10 726 | 14 173 | 14 173 | 14 699 | 16 636 |
| Item | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 29 137 | 33 656 | 33 656 | 54 750 | 71 898 |
| Equity | 28 604 | 32 052 | 32 052 | 54 471 | 71 107 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 533 | 1 604 | 1 604 | 280 | 791 |
| Total debt | 533 | 1 604 | 1 604 | 280 | 791 |
EBITDA margin
-5500000.0%
This company
15.8%
Market median
-34810227% vs market
20212024
Equity ratio
98.9%
This company
38.2%
Market median
+159% vs market
20212024
Return on equity
23.4%
This company
18.4%
Market median
+27% vs market
20212024
Net profit margin
1663600000.0%
This company
8.1%
Market median
+20538271505% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-05-01 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LG Chief Executive Officer | Chief Executive Officer | 2020 |
PF Chief Auditor | Chief Auditor | 2024 |
| Former (3) | ||
IM Chief Auditor | Chief Auditor | 2022 – 2024 |
KJ Chief Auditor | Chief Auditor | 2020 – 2022 |
KL Chief Auditor | Chief Auditor | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (7) | ||
| Chairman | 2020 – 2023 | |
| Deputy Board Member | 2020 – 2024 | |
| Board of Directors | 2020 – 2023 | |
| Chairman | 2023 – 2024 | |
| Deputy Board Member | 2024 – 2024 | |
| Board of Directors | 2024 – 2024 | |
| Board of Directors | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Linné IVF AB 
Carl Von Linnékliniken AktiebolagBoard members of Linné IVF AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Gustaf Thomas Brodin | Chief Executive Officer | 0 companies |
| Petter Fredrik Engdahl | Chief Auditor | 0 companies |
| Ida Maria Brandt | Chief Auditor | 0 companies |
| Kurt Johan Rikard Rönnblom | Chief Auditor | 0 companies |
| Karl Leonard Daun | Chief Auditor | 0 companies |
| Marcos Bueso Sanchis | Chairman | 0 companies |
| Karl Martin Torbjörn Bergh | Deputy Board Member | 0 companies |
| Anna Karin Helena Lind | Deputy Board Member | 0 companies |
| Laura Francesca Rienzi | Board of Directors | 0 companies |
| Karl Henrik Hernander | Chairman | 0 companies |
| Eva Anna-Carin Strandberg | Board of Directors | 0 companies |
| Anna Karolina Anbratt | Deputy Board Member | 0 companies |
| Eugene Maxwell Marsden | Board of Directors | 0 companies |
| Jan Gunnar Wilhelm Holte | Board of Directors | 0 companies |